Invention Grant
- Patent Title: Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
-
Application No.: US13989119Application Date: 2011-11-23
-
Publication No.: US09782474B2Publication Date: 2017-10-10
- Inventor: Deborah Long , Jessica Flechtner , Mojca Skoberne
- Applicant: Deborah Long , Jessica Flechtner , Mojca Skoberne
- Applicant Address: US MA Cambridge
- Assignee: Genocea Biosciences, Inc.
- Current Assignee: Genocea Biosciences, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Choate, Hall & Stewart, LLP
- Agent Brenda Herschbach Jarrell; Rolando Medina
- International Application: PCT/US2011/062120 WO 20111123
- International Announcement: WO2012/074881 WO 20120607
- Main IPC: A61K39/245
- IPC: A61K39/245 ; A61K39/12 ; A61K39/205 ; A61K39/00
Abstract:
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. Highly effective vaccines and immunogenic compositions against HSV-2, which can be used therapeutically or prophylactically, are described.
Public/Granted literature
- US20130337000A1 VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE Public/Granted day:2013-12-19
Information query
